Correlation Between Avinger and Bionano Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avinger and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avinger and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avinger and Bionano Genomics, you can compare the effects of market volatilities on Avinger and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avinger with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avinger and Bionano Genomics.

Diversification Opportunities for Avinger and Bionano Genomics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Avinger and Bionano is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Avinger and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Avinger is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avinger are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Avinger i.e., Avinger and Bionano Genomics go up and down completely randomly.

Pair Corralation between Avinger and Bionano Genomics

Given the investment horizon of 90 days Avinger is expected to generate 1.08 times more return on investment than Bionano Genomics. However, Avinger is 1.08 times more volatile than Bionano Genomics. It trades about -0.06 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.16 per unit of risk. If you would invest  118.00  in Avinger on September 12, 2024 and sell it today you would lose (36.00) from holding Avinger or give up 30.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Avinger  vs.  Bionano Genomics

 Performance 
       Timeline  
Avinger 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avinger has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Avinger and Bionano Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avinger and Bionano Genomics

The main advantage of trading using opposite Avinger and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avinger position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.
The idea behind Avinger and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance